Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Cuprizone decreases intermediate and late-stage progenitor cells in hippocampal neurogenesis of rats in a framework of 28-day oral dose toxicity study.
Role of T Follicular Helper cells in Multiple Sclerosis.
Corrigendum to "Cardiovascular autonomic dysfunction in multiple sclerosis: A meta-analysis" [Mult. Scler. Relat. Disord. 4 (2015) 104-111].
Selective upregulation of scavenger receptors in and around demyelinating areas in multiple sclerosis.
Chloroquine treatment enhances regulatory T cells and reduces the severity of experimental autoimmune encephalomyelitis.
Mir-155 as a multiple sclerosis-relevant regulator of myeloid cell polarization.
Anti-neurofascin antibody in patients with combined central and peripheral demyelination.
Cell-Based Reparative Therapies for Multiple Sclerosis.
Aerobic intensity and pacing pattern during the six-minute walk-test in patients with multiple sclerosis.
Environmental enrichment and brain repair: Harnessing the therapeutic effects of cognitive stimulation and physical activity to enhance experience-dependent plasticity.
The conceptualization and development of a patient-reported neurogenic bladder symptom score.
Thalamic atrophy predicts cognitive impairment in relapsing remitting multiple sclerosis. Effect on instrumental activities of daily living and employment status.
An unusually dry story.
Increased contrast enhancing lesion activity in relapsing-remitting multiple sclerosis migraine patients.
A(H1N1) vaccination recruits T lymphocytes to the choroid plexus for the promotion of hippocampal neurogenesis and working memory in pregnant mice.
Bladder and bowel dysfunction affect quality of life. A cross sectional study of 60 patients with aquaporin-4 antibody positive Neuromyelitis Optica spectrum disorder.
Levels and actions of neuroactive steroids in the nervous system under physiological and pathological conditions: Sex-specific features.
Aging of the cingulum in the human brain: Preliminary study of a diffusion tensor imaging study.
T1- Thresholds in Black Holes Increase Clinical-Radiological Correlation in Multiple Sclerosis Patients.
Coenzyme Q10 supplementation and multiple sclerosis.
Evaluating the safety and efficacy of dextromethorphan/quinidine in the treatment of pseudobulbar affect.
How do we manage and treat a patient with multiple sclerosis at risk of tuberculosis?
Rate and Predictors of Serious Neurologic Causes of Dizziness in the Emergency Department.
Multiple sclerosis for nurse practitioners.
Demyelinating disease: Novel markers for disease severity in neuromyelitis optica.
Pages
« first
‹ previous
…
568
569
570
571
572
573
574
575
576
…
next ›
last »